Mersana Therapeutics (MRSN) on Watch on Chatter
Get Alerts MRSN Hot Sheet
Join SI Premium – FREE
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Mersana Therapeutics (NASDAQ: MRSN) on watch on chatter, Takeda and Sanofi could be vying for the company.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Inspirato Said in Talks to Merge with Thayer Ventures Acquisition (TVAC) - Bloomberg (Earlier)
- D and Z Media Acquisition (DNZ) Said in Talks to Merge with Simplifi - Bloomberg
- Apple (AAPL) May Scrap iPhone Mini Next Year, New Lineup to Focus on Camera Quality, Says Top Analyst
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!